These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3622861)

  • 1. [The clinical significance of the measurement of plasma transferrin as a growth factor. II. The changes in various endocrine status].
    Matsubara M; Odagaki E; Morioka T; Nakagawa K
    Nihon Naibunpi Gakkai Zasshi; 1987 May; 63(5):669-74. PubMed ID: 3622861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma transferrin levels in abnormal endocrine states. II. The changes in various endocrine states.
    Matsubara M; Koyanagawa Y; Odagaki E; Nakagawa K
    Horm Metab Res; 1989 Jun; 21(6):334-7. PubMed ID: 2777192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of the measurement of plasma transferrin as a growth factor. I. The changes in hypophysial diseases before and after treatment].
    Matsubara M; Nakagawa K; Akikawa K
    Nihon Naibunpi Gakkai Zasshi; 1986 Nov; 62(11):1259-65. PubMed ID: 3803632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma transferrin levels in abnormal endocrine states. I. The changes in hypophysial diseases before and after treatment.
    Matsubara M; Nakagawa K; Akikawa K
    Horm Metab Res; 1988 Aug; 20(8):506-9. PubMed ID: 3181869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radioimmunoassay of serum testosterone--results of the study of normal subjects and patients with endocrine disorders].
    Baba H
    Nihon Naibunpi Gakkai Zasshi; 1973 Jan; 49(1):60-79. PubMed ID: 4734772
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma 7B2 (a novel pituitary protein) immunoreactivity concentrations in patients with various endocrine disorders.
    Natori S; Iguchi H; Ohashi M; Nawata H
    Endocrinol Jpn; 1988 Aug; 35(4):651-4. PubMed ID: 2850908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum leptin levels in women with anorexia nervosa.
    Grinspoon S; Gulick T; Askari H; Landt M; Lee K; Anderson E; Ma Z; Vignati L; Bowsher R; Herzog D; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3861-3. PubMed ID: 8923829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isotopic composition of blood plasma carbon in patients with endocrine diseases].
    Ivlev AA; Goncharov NP
    Probl Endokrinol (Mosk); 1993; 39(1):36-40. PubMed ID: 8058661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematologic alteration associated with endocrine disease.
    Donati RM; Gallagher NI
    Med Clin North Am; 1968 Mar; 52(2):231-41. PubMed ID: 4872206
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in somatomedin activity in anorexia nervosa.
    Tanaka T; Maesaka H; Suwa S
    Endocrinol Jpn; 1985 Dec; 32(6):891-7. PubMed ID: 3833530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the mechanism of abnormal growth hormone (GH) secretion in anorexia nervosa: no evidence of involvement of a low somatomedin-C level in the abnormal GH secretion.
    Masuda A; Shibasaki T; Hotta M; Suematsu H; Shizume K
    J Endocrinol Invest; 1988 Apr; 11(4):297-302. PubMed ID: 3137254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of somatomedin-C and triiodothyronine in patients with thyroid dysfunction and nonthyroidal illnesses.
    Välimäki M; Liewendahl ; Karonen SL; Helenius T; Suikkari AM
    J Endocrinol Invest; 1990 Feb; 13(2):155-9. PubMed ID: 2329260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of thyroid hormone therapy on plasma insulin-like growth factor I levels in normal subjects, hypothyroid patients and endemic cretins.
    Cavaliere H; Knobel M; Medeiros-Neto G
    Horm Res; 1987; 25(3):132-9. PubMed ID: 3570152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid receptors in anorexia nervosa and Cushing's disease.
    Invitti C; Redaelli G; Baldi G; Cavagnini F
    Biol Psychiatry; 1999 Jun; 45(11):1467-71. PubMed ID: 10356629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible relationship between serum transferrin, growth hormone secretion and height velocity in children.
    Donnadieu M; Schimpff RM; Garnier P; Chaussain JL; Job JC
    Acta Endocrinol (Copenh); 1980 Feb; 93(2):134-8. PubMed ID: 7376785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum transferrin as a marker of bone growth in boys: correlation with serum alkaline phosphatase activity, plasma insulin-like growth factor 1 and rate of growth in height.
    Misaki M; Shima T; Yano Y; Okazaki T
    Horm Metab Res; 1991 May; 23(5):230-2. PubMed ID: 1874482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum T3 and T4 levels in patients with anorexia nervosa showing transient hyperthyroidism during weight gain.
    Moore R; Mills IH
    Clin Endocrinol (Oxf); 1979 May; 10(5):443-9. PubMed ID: 476976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary-hypothalamic response in adolescents with growth failure due to fear of obesity.
    Pugliese M; Lifshitz F; Fort P; Recker B; Ginsberg L
    J Am Coll Nutr; 1987 Apr; 6(2):113-20. PubMed ID: 3108348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoreactive somatomedin B (RIA-B) in the circulation of healthy adults and patients with endocrine disorders.
    Tham A; Sara VR; Bäckström M; Hall K; Kallner G; Ljunggren JG; Wetterberg L
    Horm Metab Res; 1986 Oct; 18(10):706-9. PubMed ID: 3781477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme and anorexia nervosa.
    Matsubayashi S; Tamai H; Kobayashi N; Takaichi Y; Fukata S; Hirota Y; Kuma K; Nakagawa T; Kumagai LF
    Horm Metab Res; 1988 Dec; 20(12):761-4. PubMed ID: 2851517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.